`
`
`
`
`
`
`Entered: November 23, 2015
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________________
`
`PRAXAIR DISTRIBUTION, INC.
`Petitioner
`
`v.
`
`INO THERAPEUTICS LLC,
`Patent Owner
`_______________________
`
`Case IPR2015-00891
`U.S. Patent No. 8,573,210 B2
`_______________________
`
`Before KEN B. BARRETT, MICHAEL J. FITZPATRICK, AND
`SCOTT A. DANIELS, Administrative Patent Judges.
`
`
`
`PATENT OWNER’S UPDATED EXHIBIT LIST
`
`
`
`
`
`
`
`
`
`Case IPR2015-00891
`U.S. Patent No. 8,573,210
`
`
`Pursuant to 37 C.F.R. § 42.63(e), Patent Owner INO Therapeutics LLC
`
`(“Ikaria”) respectfully submits the following current exhibit list:
`
`2002
`
`2003
`
`2004
`
`2005
`
`2006
`
`2007
`2008
`
`2009
`
`2010
`
`EXHIBIT DESCRIPTION
`2001
`Drugs@FDA, Application No. NDA 020845, INOMAX – nitric
`oxide gas, Labeling Revision (Revised: 3/2013), available at
`http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/0208
`45s014lbl.pdf
`INOmax DSIR® (Delivery System) Operation Manual (800 ppm
`INOMAX® (nitric oxide) for inhalation), Part No. 20010 Rev-
`05, 2012-03, available at
`http://inomax.com/wpcontent/uploads/2015/01/20010_rev_05_INO
`max_DSIR_Operation_Manual_with_Links.pdf
`U.S. Patent Application No. 13/509,873 File History – Non-Final
`Rejection and Notice of References Cited mailed March 15, 2013
`U.S. Patent Application No. 13/509,873 File History –
`Applicant-Initiated Interview Summary mailed May 23, 2013
`U.S. Patent Application No. 13/509,873 File History –
`Amendment/Response Under 37 C.F.R. § 1.111 filed June 17, 2013
`U.S. Patent Application No. 13/509,873 File History – Notice of
`Allowance and Fee(s) Due mailed August 19, 2013
`Patent Owner’s Updated Power of Attorney
`Declaration of David K. Callahan in Support of Patent Owner INO
`Therapeutics LLC’s Motion for Pro Hac Vice Admission Under 37
`C.F.R. § 42.10(c)
`Declaration of Kenneth G. Schuler in Support of Patent Owner INO
`Therapeutics LLC’s Motion for Pro Hac Vice Admission Under 37
`C.F.R. § 42.10(c)
`Declaration of Marc N. Zubick in Support of Patent Owner INO
`Therapeutics LLC’s Motion for Pro Hac Vice Admission Under 37
`C.F.R. § 42.10(c)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Dated: November 23, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`By: /Robert Steinberg/
`
`
`
`
`
`
`Respectfully submitted,
`
`1
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Robert Steinberg (Reg. No. 33,144)
`bob.steinberg@lw.com
`Latham & Watkins LLP
`355 South Grand Avenue
`Los Angeles, CA 90071-1560
`213.485.1234; 213.891.8763 (Fax)
`
`Daniel G. Brown (Reg. No. 54,005)
`daniel.brown@lw.com
`Latham & Watkins LLP
`885 Third Avenue
`New York, NY 10022-4834
`212.906.1200; 212.751.4864 (Fax)
`
`Counsel for Patent Owner
`
`2
`
`Case IPR2015-00891
`U.S. Patent No. 8,573,210
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2015-00891
`U.S. Patent No. 8,573,210
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that on this 23rd day of
`
`November, 2015, a true and correct copy of the foregoing Patent Owner’s
`
`Updated Exhibit List was served by electronic mail on Petitioner’s lead and
`
`backup counsel at the following email addresses:
`
`sanjay.murthy@klgates.com
`
`sara.kerrane@klgates.com
`
`michael.abernathy@klgates.com
`
`margaux.nair@klgates.com
`
`maria.doukas@klgates.com
`
`Praxair-Ikaria@klgates.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`By: /Robert Steinberg/
`
`Robert Steinberg (Reg. No. 33,144)
`bob.steinberg@lw.com
`Latham & Watkins LLP
`355 South Grand Avenue
`Los Angeles, CA 90071-1560
`213.485.1234; 213.891.8763 (Fax)